Severe Raynaud's phenomenon with yohimbine therapy for erectile dysfunction.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 14677199.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Yohimbine is a selective alpha-2 adrenergic antagonist that has been used in the pharmacologic management of erectile dysfunction (ED). We describe a patient with CREST syndrome (calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, and telangiectasia) who paradoxically experienced worsening of Raynaud's phenomenon when using yohimbine for ED.
Medical subject headings
- Adrenergic alpha-Antagonists
- CREST Syndrome
- Erectile Dysfunction
- Raynaud Disease
- Yohimbine